MTEK
Maris-Tech Ltd.
There isn't enough reported data to score MTEK yet.
NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
MTEK Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Strong |
MTEK's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
MTEK PE Valuation
MTEK has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
MTEK Forward outlook
There aren't enough analyst estimates for MTEK to show an outlook.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
MTEK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$0.67 | -$0.51 |
| Q2 2025 | -$0.48 | -$0.45 |
| Q4 2024 | -$0.16 | +$0.18 |
MTEK lost $0.67 per share over the past year, and its loss has widened in each of the last three quarters.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over MTEK in the latest year-over-year earnings comparison.
MTEK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.1M | +194% |
| Q4 2025 | $634.2K | -76% |
| Q2 2025 | $707K | -79% |
| Q4 2024 | $2.7M | -25% |
| Q2 2024 | $3.4M | +620% |
| Q4 2023 | $3.6M | +131% |
| Q2 2023 | $473.9K | -51% |
| Q4 2022 | $1.5M | +106% |
MTEK's revenue has slid since its 2023 peak: $2M last quarter, down 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -101% | -102 points |
| Q4 2025 | -464% | -450 points |
| Q2 2025 | -323% | +189 points |
| Q4 2024 | -52% | -441 points |
| Q2 2024 | 1.4% | +238 points |
| Q4 2023 | -14% | +53 points |
| Q2 2023 | -512% | -507 points |
| Q4 2022 | 389% | +440 points |
MTEK's operating margin was −101% last quarter, down 102 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over MTEK in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over MTEK on profitability, with a higher operating margin.
MTEK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.8M | -$1.5M |
| Q4 2025 | -$2.1M | -$879.6K |
| Q2 2025 | -$1.3M | -$141.3K |
| Q4 2024 | -$1.3M | +$386.7K |
| Q2 2024 | -$1.2M | +$1.2M |
| Q4 2023 | -$1.6M | +$489.4K |
| Q2 2023 | -$2.3M | +$690.5K |
| Q4 2022 | -$2.1M | -$2M |
MTEK has burned cash in almost every quarter: −$7M over the past year, against −$7M the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA's free cash flow has been positive every quarter for six years: $127B over the past year, up 76% from the year before.
MTEK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2022 | -0.1x | Net Cash |
MTEK has more cash than debt.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
MTEK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.4 | Oversold |
| Stochastic | 5.1 | Oversold |
MTEK's weekly RSI is 27 (oversold) and its Stochastic is 5 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
MTEK PE vs Technology Sector
MTEK has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
MTEK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.52 | 44% below |
| 20 week MA | $0.86 | 66% below |
| 50 week MA | $1.19 | 76% below |
| 100 week MA | $1.94 | 85% below |
| 200 week MA | $1.61 | 82% below |
MTEK is in a downtrend: it's below all five of its weekly moving averages, and 82% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over MTEK on trend strength, trading above more of its moving averages.
MTEK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $2.70 | $0.77 | -71% |
| 2023 | $0.77 | $1.04 | +35% |
| 2024 | $1.04 | $4.80 | +362% |
| 2025 | $4.80 | $1.22 | -75% |
| 2026 YTD | $1.22 | $0.29 | -76% |
MTEK's yearly returns have swung widely, from +362% in 2024 to −75% in 2025. It's down 76% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over MTEK on returns for 2026, with the stronger performance.